Critical appraisal of the use of regorafenib in the management of colorectal cancer

The lack of valid clinical management options for patients affected by metastatic colorectal cancer, which has progressed after all approved standard treatments, has lead to research into new active molecules. Regorafenib is an oral small-molecule multi kinase inhibitor, binding to several intracell...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Festino, Lucia, Fabozzi, Alessio, Manzo, Anna, Gambardella, Valentina, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Ciardiello, Fortunato, Morgillo, Floriana
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2013
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3628528/
https://ncbi.nlm.nih.gov/pubmed/23610528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S34281
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg